Cargando…
MiR-93 is related to poor prognosis in pancreatic cancer and promotes tumor progression by targeting microtubule dynamics
Biomarkers and effective therapeutic agents to improve the dismal prognosis of pancreatic ductal adenocarcinoma (PDAC) are urgently required. We aimed to analyze the prognostic value and mechanistic action of miR-93 in PDAC. Correlation of miR-93 tumor levels from 83 PDAC patients and overall surviv...
Autores principales: | Vila-Navarro, Elena, Fernandez-Castañer, Elena, Rovira-Rigau, Maria, Raimondi, Giulia, Vila-Casadesus, Maria, Lozano, Juan Jose, Soubeyran, Philippe, Iovanna, Juan, Castells, Antoni, Fillat, Cristina, Gironella, Meritxell |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198506/ https://www.ncbi.nlm.nih.gov/pubmed/32366853 http://dx.doi.org/10.1038/s41389-020-0227-y |
Ejemplares similares
-
Deciphering microRNA targets in pancreatic cancer using miRComb R package
por: Vila-Casadesús, Maria, et al.
Publicado: (2018) -
MicroRNAs Deregulated in Intraductal Papillary Mucinous Neoplasm Converge on Actin Cytoskeleton-Related Pathways That Are Maintained in Pancreatic Ductal Adenocarcinoma
por: Fernandez-Castañer, Elena, et al.
Publicado: (2021) -
Novel Circulating miRNA Signatures for Early Detection of Pancreatic Neoplasia
por: Vila-Navarro, Elena, et al.
Publicado: (2019) -
MiRComb: An R Package to Analyse miRNA-mRNA Interactions. Examples across Five Digestive Cancers
por: Vila-Casadesús, Maria, et al.
Publicado: (2016) -
MicroRNAs for Detection of Pancreatic Neoplasia: Biomarker Discovery by Next-generation Sequencing and Validation in 2 Independent Cohorts
por: Vila-Navarro, Elena, et al.
Publicado: (2017)